Multiple sclerosis: Interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images

Journal of Neurology

Volumn 246, Issue 10, 1999, Pages 920-925

  Rovaris, M ^a   Barkhof, F ^b   Bastianello, S ^c   Gasperini, C ^c   Tubridy, N ^d   Yousry, T A ^e   Sormani, M P ^a,f   Viti, B ^a   Miller, D H ^d   Filippi, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Disease activity; Fast fluid attenuated inversion recovery; Fast spin echo; Magnetic resonance imaging; Multiple sclerosis; Reproducibility

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0032714913     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050483     Document Type: Article

References (31)

1. Barkhof F, Scheltens P, Frequin STMF, et al (1992) Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 159:1041-1047
2. Barkhof F, Filippi M, Miller DH, et al (1997) Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis. J Neurol 244:76-84
3. Barkhof F, Filippi M, van Waesberghe JH, et al (1997) Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 49:1682-1688
4. Bastianello S, Bozzao A, Paolillo A, et al (1997) Fast spin-echo and fast fluidattenuated inversion recovery sequences versus conventional spin-echo for MR quantification of multiple sclerosis lesions. Am J Neuroradiol AJNR Am J Neuroradiol 18:699-704
5. Filippi M, Miller DH (1996) MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 9:176-186
6. Filippi M, Yousry T, Campi A, et al (1996) Comparison of triple close versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 46:379-384
7. Filippi M, Barkhof F, Bressi S, Yousry TA, Miller DH (1997) Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis. Mult Scler 3:226-230
8. Filippi M, Mastronardo G, Bastianello S, et al (1998) A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis. J Neurol Sci 159:94-101
9. Filippi M, Rocca MA, Gasperini C, et al (1999) Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin echo, rapid relaxation-enhanced and fast-FLAIR sequences. Am J Neuroradiol AJNR Am J Neuroradiol 20:133-137
10. Gawne-Cain ML, O'Riordan JI, Thompson AJ, Moseley IF, Miller DH (1997) Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin echo. Neurology 49:364-370
11. Gawne-Cain ML, O'Riordan JI, Coles A, et al (1998) MRI lesion volume measurement in MS and its correlation with disability: a comparison of fast-FLAIR and spin echo sequences. J Neurol Neurosurg Psychiatry 64:197-203
12. Goodkin DE, Ross JS, Vanderbrug Medendorp S, Konecsni J, Rudick RA (1992) Magnetic resonance imaging enlargement in multiple sclerosis. Disease-related activity, chance occurrence or measurement artifact? Arch Neurol 49:261-263
13. Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH (1986) Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161:721-725
14. Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF (1991) Serial Gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 29:548-555
15. Koudriavtseva T, Thompson AJ, Fiorelli M, et al (1997) Gadolinium-enhanced MRI predicts clinical and MRI activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 62:285-287
16. Lai M, Hodgson T, Gawne-Cain M, et al (1996) A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 60:339-341
17. Lee MA, Smith S, Palace J, Matthews PM (1998) Defining multiple sclerosis activity using MRI T2-weighted difference imaging. Brain 121:2095-2102
18. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
19. McFarland HF, Frank JA, Albert PS, et al (1992) Using gadolinium-enhanced magnetic resonance imaging to monitor disease activity in multiple sclerosis. Ann Neurol 32:758-766
20. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683-688
21. Miller DH, Barkhof F, Nauta JJP (1993) Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS. Brain 116:1077-1094
22. Miller DH, Albert PS, Barkhof F, et al (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39:6-16
23. Molyneux P, Filippi M, Barkhof F, et al (1998) Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 43:332-339
24. Molineux PD, Miller DH, Filippi M, et al (1998) Intra-and inter-observer variation in reporting activity on serial T2 weighted brain MR images in multiple sclerosis (abstract). In: Proceedings of Sixth Scientific Meeting of the International Society for Magnetic Resonance in Medicine vol 2, pp 1330
25. Nauta JJP, Thompson AJ, Barkhof F, Miller DH (1994) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs. J Neurol Sci 122:6-14
26. Poser CM, Paty DW, Scheinberg L, et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
27. Rydberg JN, Riederer SJ, Rydberg CH, Jack CR (1996) Contrast optimization of fluid attenuated inversion recovery (FLAIR) imaging. Magn Reson Med 34:868-877
28. Silver NC, Good CD, Barker GJ, et al (1997) Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetisation transfer contrast and delayed imaging. Brain 120:1149-1161
29. Thorpe JW, Halpin SF, MacManus DG, Barker GJ, Kendall BE, Miller DH (1994) A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 36:388-392
30. Truyen L, Barkhof F, Tas M, et al (1997) Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials. Mult Scler 2:283-290
31. Yousry TA, Filippi M, Becker C, Horsfield MA, Voltz R, Reiser MF (1997) Comparison of SE, FSE, fastFLAIR and TGSE sequences in detecting multiple sclerosis lesions. Am J Neuroradiol AJNR Am J Neuroradiol 18:959-963